Larson Financial Group’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68K Buy
398
+1
+0.3% +$127 ﹤0.01% 1375
2026
Q1
$37.7K Buy
397
+7
+2% +$858 ﹤0.01% 1507
2025
Q4
$64.2K Buy
390
+4
+1% +$531 ﹤0.01% 1116
2025
Q3
$39.9K Hold
386
﹤0.01% 1259
2025
Q2
$48.1K Hold
386
﹤0.01% 1087
2025
Q1
$18.2K Hold
386
﹤0.01% 1403
2024
Q4
$12.2K Hold
386
﹤0.01% 1414
2024
Q3
$8.38K Sell
386
-1
-0.3% -$14 ﹤0.01% 1547
2024
Q2
$2.3K Hold
387
﹤0.01% 1577
2024
Q1
$5.56K Hold
387
﹤0.01% 1173
2023
Q4
$10.4K Hold
387
﹤0.01% 1004
2023
Q3
$11.7K Buy
+387
New +$18.7K ﹤0.01% 956

Other funds holding NUTX

Larson Financial Group's NUTX Position: Q2 2026 in Review

Larson Financial Group increased its Nutex Health (NUTX) stake by 0.25% in Q2 2026, buying an estimated $127 and bringing the position to 398 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Larson Financial Group first reported a position in NUTX in Q3 2023 and has held it in 12 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Larson Financial Group held 398 shares of Nutex Health worth $68K as of Q2 2026.
  • Larson Financial Group bought 1 Nutex Health share in Q2 2026, an estimated $127.
  • Nutex Health made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1375 holding.
  • Larson Financial Group first reported a position in Nutex Health in Q3 2023 and has held it in 12 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.